$42.50
-1.15-2.63%
Pre-Market: 7:00 AM EDT
Comments
Loading...
Avidity Biosciences (RNA) Forecast
NewsEarningsAvidity Biosciences (RNA) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAvidity Biosciences (NASDAQ:RNA) Stock Quotes, Forecast and News Summary
Avidity Biosciences Stock (NASDAQ: RNA) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Avidity Biosciences (RNA) stock?
You can purchase shares of Avidity Biosciences (NASDAQ:RNA) through any online brokerage.
Who are Avidity Biosciences (RNA) competitors?
Other companies in Avidity Biosciences’s space includes: Immunovant (NASDAQ:IMVT), Legend Biotech (NASDAQ:LEGN), Ultragenyx Pharmaceutical (NASDAQ:RARE), Ionis Pharmaceuticals (NASDAQ:IONS) and Roivant Sciences (NASDAQ:ROIV).
What is the forecast, or price target, for Avidity Biosciences (RNA) stock?
Avidity Biosciences has a consensus price target of $56.92.
What is the current price for Avidity Biosciences (RNA)?
The stock price for Avidity Biosciences (NASDAQ: RNA) is $42.5 last updated November 21, 2024 at 7:00 AM EST.
Does Avidity Biosciences (RNA) pay a dividend?
There are no upcoming dividends for Avidity Biosciences.
When is Avidity Biosciences (NASDAQ:RNA) reporting earnings?
Avidity Biosciences’s Q3 earnings are confirmed for Thursday, November 7, 2024.
Is Avidity Biosciences (RNA) going to split?
There is no upcoming split for Avidity Biosciences.
What sector and industry does Avidity Biosciences (RNA) operate in?
Avidity Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.